Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Preclinical profile of BI-397, a promising new glycopeptide antibiotic

Oct. 6, 1998

Bayer's moxifloxacin highlighted at ICAAC; approval to be sought soon

Oct. 5, 1998

Preliminary phase II data and preclinical results reported for MK-826

Oct. 5, 1998

Bisphosphonate-conjugated antibacterials for targeted drug delivery in bone infections

Oct. 5, 1998

NC-1175: novel conjugated styryl ketone with ATPase-targeted fungicidal activity

Oct. 5, 1998

CP-279107 inhibits macrolide-resistant streptococci in vitro and in vivo

Oct. 5, 1998

Versicor searches for inhibitors of bacterial ligases as novel antibiotics

Oct. 5, 1998

Novel anti-HBV nucleosides presented by Nabi at ICAAC

Oct. 5, 1998

Canadian team isolates novel anti-HSV agent from Chinese herb

Oct. 5, 1998

Linezolid in the limelight at ICAAC

Oct. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...